Grant: Project Grant

The proposed health research project aims at the development of a medical imaging assay using a novel class of drugs exerting combined anti-inflammatory and anti-cancer effects. The novel drug molecules are decorated with a radioactive atom to detect chronic inflammatory diseases like fibrosis and cancer in patients at an early disease stage with high accuracy. The novel medical imaging assay will allow physicians to look into the patient's body from the outside to find inflamed and cancerous tissue. The technology will enable physicians to select patients for the most optimal treatment option using innovative hybrid anti-inflammatory and anti-cancer drugs. This concept is in alignment with the prominent principle "to select the right treatment-for the right patient-at the right time". The treatment success and response can also be monitored with the novel medical imaging assay. A task of this magnitude is only achievable with a strong team of cancer research experts and strong partners from the health service and industrial community. Such a team has been assembled for the project to ultimately enhance patient care, especially with difficult to treat diseases like chronic inflammation and cancer.